Daniel Christoph Amberger
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 14, 2026
Modulation of Leukemic Blasts into Dendritic Cells (DC<sub>leu</sub>) and Their Role in Predicting Survival in Patients with AML and MDS.Daniel Christoph Amberger, Zuzana Fischer, Diana Deen
|Feb 26, 2025
Leukemia-Derived Dendritic Cells Induce Anti-Leukemic Effects Ex Vivo in AML Independently of Patients' Clinical and Biological Features.Lara Kristina Klauer, Hazal Aslan Rejeski, Selda Ugur
|Jan 08, 2025
In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers.Michael Atzler, Tobias Baudrexler, Daniel Christoph Amberger
|Jan 08, 2023
Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.Elias Rackl, Lin Li, Lara Kristina Klauer
|Aug 12, 2022
Generation of Leukaemia-Derived Dendritic Cells (DC<sub>leu</sub>) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations.Christoph Schwepcke, Lara Kristina Klauer, Diana Deen
Pageof 1
